chr14-45136202-G-C
Variant summary
Our verdict is Benign. Variant got -13 ACMG points: 0P and 13B. BP4_StrongBP6BS1BS2
The NM_020937.4(FANCM):āc.171G>Cā(p.Leu57Phe) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00236 in 1,614,190 control chromosomes in the GnomAD database, including 9 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Conflicting classifications of pathogenicity (no stars).
Frequency
Consequence
NM_020937.4 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Benign. Variant got -13 ACMG points.
Transcripts
RefSeq
Ensembl
Frequencies
GnomAD3 genomes AF: 0.00155 AC: 236AN: 152180Hom.: 1 Cov.: 32
GnomAD3 exomes AF: 0.00174 AC: 437AN: 251472Hom.: 1 AF XY: 0.00182 AC XY: 247AN XY: 135920
GnomAD4 exome AF: 0.00244 AC: 3573AN: 1461892Hom.: 8 Cov.: 32 AF XY: 0.00245 AC XY: 1782AN XY: 727248
GnomAD4 genome AF: 0.00155 AC: 236AN: 152298Hom.: 1 Cov.: 32 AF XY: 0.00152 AC XY: 113AN XY: 74466
ClinVar
Submissions by phenotype
not provided Uncertain:1Benign:3
FANCM: BS1 -
This variant is associated with the following publications: (PMID: 28881617, 29217778, 28717660, 30426508, 26517685) -
- -
- -
Hereditary cancer-predisposing syndrome Benign:2
- -
BS2, BP4_Moderate c.171G>C, located in exon 1 of the FANCM gene, is predicted to result in the substitution of leucine by phenylalanine at codon 57, p.(Leu57Phe). This variant is found in 452/268342 alleles at a frequency of 0.1% in the gnomAD v2.1.1 database, non-cancer dataset. This variant has been observed in homozygous state in multiple healthy individuals in the gnomAD v4 database (BS2). The SpliceAI algorithm predicts no significant impact on splicing. The REVEL meta-predictor score for this variant (0.064) suggests that it does not affect the protein function according to Pejaver 2022 thresholds (PMID: 36413997) (BP4_Moderate). To our knowledge, neither relevant clinical data nor well-established functional studies have been reported for this variant. It has been reported in oncologic and hemato-oncologic patients (PMID:38927643, 29217778,28717660, 26740942). This variant has been reported in the ClinVar database (2x benign, 6x likely benign, 1x uncertain significance) and in LOVD (1x likely benign, 2x uncertain significance). Based on currently available information, the variant c.171G>C should be considered a likely benign variant, according to ACMG/AMP classification guidelines. -
Spermatogenic failure 28;C4748170:Premature ovarian failure 15 Uncertain:1
FANCM NM_020937 exon 1 p.Leu57Phe (c.171G>C): This variant has not been reported in the literature but is present in 0.3% (354/126714) of European alleles in the Genome Aggregation Database (http://gnomad.broadinstitute.org/rs142007602). Evolutionary conservation and computational predictive tools for this variant are unclear. In summary, data on this variant is insufficient for disease classification. Therefore, the clinical significance of this variant is uncertain. -
not specified Benign:1
- -
Fanconi anemia Benign:1
- -
FANCM-related disorder Benign:1
This variant is classified as likely benign based on ACMG/AMP sequence variant interpretation guidelines (Richards et al. 2015 PMID: 25741868, with internal and published modifications). -
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at